Wahed Invest LLC Gilead Sciences, Inc. Transaction History

Wahed Invest LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $346,377 - $399,746	5,485 Added 22.43%	29,941 $2.05 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $237,216 - $289,279	3,314 Added 15.67%	24,456 $1.79 Million
Q4 2023 Mar 11, 2024	BUY	$73.27 - $83.09 $1.21 Million - $1.37 Million	16,463 Added 351.85%	21,142 $1.71 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.11 Million - $1.26 Million	-15,129 Reduced 76.38%	4,679 $379,000
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $131,169 - $143,108	1,774 Added 9.84%	19,808 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $1.37 Million - $1.56 Million	18,034 New	18,034 $1.39 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $60,611 - $69,234	1,018 Added 7.68%	14,270 $880,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $764,905 - $861,512	13,252 New	13,252 $819,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

Stay updated on Wahed Invest LLC with notifications on news.